How effective is biological immunotherapy for primary liver cancer?

Primary liver cancer is a common type of liver cancer. In life, the number of patients with primary liver cancer is increasing. So how much do you know about primary liver cancer? Next, let the experts analyze the biological immunotherapy for primary liver cancer so that everyone is no longer unfamiliar with it.

Experts said that the technology of biological immunotherapy for primary liver cancer has become more and more mature, and has been successfully applied to various cancer fields, all with good results. Practice has proved that biological immunotherapy for primary liver cancer is effective. Biological immunotherapy for primary liver cancer is to collect peripheral blood mononuclear cells from patients through advanced instruments, and then add a variety of cytokines to the collected mononuclear cells under sterile and strictly monitored conditions to culture them, so that the number of patients' immune cells is greatly increased, the activity is enhanced, and they are induced to become DC-CIK cell groups with strong anti-cancer effects, and finally they are returned to the patient's body through intravenous infusion to achieve the purpose of killing liver cancer cells and enhancing the patient's overall immune ability.

Patients with primary liver cancer can receive biological DC-CIK immunotherapy alone or in combination with other treatments such as surgery, radiotherapy and chemotherapy during the process of biological immunotherapy for primary liver cancer. Studies have shown that biological DC-CIK immunotherapy for primary liver cancer has a good therapeutic effect, especially for the liver cancer cells remaining in the body. It directly kills virus-infected cells and tumor cells without any harm to normal cells and the body's immune system. It is safe and reliable without side effects. After the activated cells are infused back into the body, some can reach the lesion site and exert anti-tumor activity in the body for a long time. At the same time, it can also regulate and enhance the systemic immune function, control tumor proliferation, reduce patient pain, and prevent and delay tumor recurrence and metastasis.

The above content is what experts introduced to you about biological immunotherapy for primary liver cancer. Please pay attention to it. I hope the above content can be helpful to you. If you have other questions about biological immunotherapy for primary liver cancer, please consult online experts and they will give you detailed answers.

For more information, please visit the liver cancer special topic at http://www..com.cn/zhongliu/ga/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.